Poolbeg Pharma upbeat on preliminary influenza drug results

By: TheNewswire.com

January 09, 2023 at 09:01 AM EST

Poolbeg Pharma PLC (OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after announcing initial data analysis, including a 'clear dose-related response', for its drug, POLB 001, a potential treatment for severe influenza. Skillington says the 'early data readout' indicates that the challenge trial was successful.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

More News

NVIDIA Nears Buy Zone as Rumors Swirl About China Chip Deal ↗

Today 14:23 EST

Via MarketBeat

These 3 Tech Companies Are Suddenly Paying Bigger Dividends ↗

Today 13:02 EST

Via MarketBeat

Holiday Spending to Hit $1 Trillion—Time to Buy This Retail ETF? ↗

Today 12:22 EST

Via MarketBeat

BJ’s Wholesale Club and the Case for a Bullish Market Reversal ↗

Today 11:45 EST

Via MarketBeat

Why Costco Stock May Struggle Even as Its Business Thrives ↗

Today 10:31 EST

Via MarketBeat

Recent Quotes

Symbol	Price	Change (%)
AMZN	226.06	+5.37 (2.43%)
AAPL	276.06	+4.56 (1.68%)
AMD	215.39	+11.61 (5.70%)
BAC	52.09	+0.53 (1.03%)
GOOG	318.39	+18.74 (6.25%)
META	615.20	+20.95 (3.53%)
MSFT	474.32	+2.20 (0.47%)
NVDA	181.59	+2.71 (1.51%)
ORCL	200.32	+1.56 (0.78%)
TSLA	418.20	+27.12 (6.93%)

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.